pharma · Hypertension · Breast Neoplasms
Pfizer
Pfizer is a pharma organization headquartered in PARIS, FR. Primary therapeutic focus areas include Hypertension, Breast Neoplasms, Complicated Intra-abdominal Infection, Non-Small Cell Lung Cancer, Arthritis, Rheumatoid
New York 10017, US HQ
103,316 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- New York 10017, US
- Employees
- 103,316
- Programs
- 98
- Drugs
- 80
- Patents
- 0
inotuzumab ozogamicin-dose level 2
Approved · small molecule · Leukemia
inotuzumab ozogamicin-dose level 2 for Leukemia is a Approved program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Internal code B1931030
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Pfizer
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Leukemia
- Status
- completed
- Trials
- 1